Human verification ‘will be rare and will not apply to most users,’ according to Reddit CEO Steve Huffman. Human verification ‘will be rare and will not apply to most users,’ according to Reddit CEO ...

You don't need to be a developer to build your own crypto bot. Here's how traders are doing it in 30 minutes, for free.

March 13 (Reuters) - Digg is laying off staff citing "brutal reality" in the current digital environment and a surge in artificial intelligence-driven bot activity, more than a year after the ...

Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. And boy, is Grok doing ...

The viral virtual assistant OpenClaw—formerly known as Moltbot, and before that Clawdbot—is a symbol of a broader revolution underway that could fundamentally alter how the internet functions. Instead ...

If you’re following AI on social media, even lightly, you will likely have come across OpenClaw. If not, you will have heard one of its previous names, Clawdbot or Moltbot. Despite its technical ...

The company will invest in market expansion and accelerating product capabilities. Bot mitigation specialist Kasada today announced raising $20 million in a funding round that brings the total raised ...

The Markup, now a part of CalMatters, uses investigative reporting, data analysis, and software engineering to challenge technology to serve the public good. Sign up for Klaxon, a newsletter that ...

The New Scientist Book Club moved on from reading a classic piece science fiction in December – Iain M. Banks’s The Player of Games – to an award-winning sci-fi novel in January: Sierra Greer’s Annie ...

Cross Bot will analyze your games in Crossplay, a new two-player word game from The Times. By Asmaa Elkeurti Tom Giratikanon and Eve Washington New York Times Games has launched Crossplay, a new ...

Botensilimab and balstilimab combination therapy is approved in France for ovarian cancers and soft tissue sarcomas under the AAC framework. The therapy, initially for microsatellite-stable metastatic ...